Literature DB >> 24127823

Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection.

Rong-Fu Chen1, Chun-Yi Lee.   

Abstract

Adenovirus is a common infectious pathogen in both children and adults. It is a significant cause of morbidity in immunocompetent people living in crowded living conditions and of mortality in immunocompromised hosts. It has more recently become a popular vehicle for gene therapy applications. The host response to wild-type infection and gene therapy vector exposure involves both virus entry receptor and the innate immune systems. Cell-mediated recognition of viruses via capsid components has received significant attention, principally thought to be regulated by the coxsackievirus-adenovirus receptor (CAR), CD46, integrins and heparin sulfate-containing proteoglycans. Antiviral innate immune responses are initiated by the infected cell, which activates the interferon response to block viral replication, while simultaneously releasing chemokines to attract neutrophils and NK cells. This review discusses the innate immune response primarily during wild-type adenovirus infection because this serves as the basis for understanding the response during both natural infection and exposure to adenovirus vectors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24127823     DOI: 10.3109/08830185.2013.823420

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  27 in total

Review 1.  Adenovirus: the first effective in vivo gene delivery vector.

Authors:  Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2014-01       Impact factor: 5.695

Review 2.  Multivalent and Multipathogen Viral Vector Vaccines.

Authors:  Katharina B Lauer; Ray Borrow; Thomas J Blanchard
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

3.  [Adenoviral keratoconjunctivitis].

Authors:  U Pleyer; F Birnbaum
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

4.  Longitudinal quantification of adenovirus neutralizing responses in Zambian mother-infant pairs: Impact of HIV-1 infection and its treatment.

Authors:  Sara R Privatt; Brianna L Bullard; Eric A Weaver; Charles Wood; John T West
Journal:  Vaccine       Date:  2019-08-01       Impact factor: 3.641

5.  The neostriatum: two entities, one structure?

Authors:  Violeta G Lopez-Huerta; Yoko Nakano; Johannes Bausenwein; Omar Jaidar; Michael Lazarus; Yoan Cherassse; Marianela Garcia-Munoz; Gordon Arbuthnott
Journal:  Brain Struct Funct       Date:  2015-02-05       Impact factor: 3.270

6.  Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012).

Authors:  Michelle C Crank; Eleanor M P Wilson; Laura Novik; Mary E Enama; Cynthia S Hendel; Wenjuan Gu; Martha C Nason; Robert T Bailer; Gary J Nabel; Adrian B McDermott; John R Mascola; Richard A Koup; Julie E Ledgerwood; Barney S Graham
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

Review 7.  Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma.

Authors:  Wojciech K Panek; J Robert Kane; Jacob S Young; Aida Rashidi; Julius W Kim; Deepak Kanojia; Maciej S Lesniak
Journal:  Oncotarget       Date:  2017-09-11

8.  Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma.

Authors:  Akiko Harada; Junji Uchino; Taishi Harada; Noriaki Nakagaki; Junko Hisasue; Masaki Fujita; Koichi Takayama
Journal:  Cancer Sci       Date:  2016-12-01       Impact factor: 6.716

Review 9.  How genetically engineered systems are helping to define, and in some cases redefine, the neurobiological basis of sleep and wake.

Authors:  Patrick M Fuller; Akihiro Yamanaka; Michael Lazarus
Journal:  Temperature (Austin)       Date:  2015-10-12

10.  Transduction of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic pathway.

Authors:  Efrain Guzman; Geraldine Taylor; Jayne Hope; Rebecca Herbert; Carolina Cubillos-Zapata; Bryan Charleston
Journal:  J Gen Virol       Date:  2016-08-15       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.